Key result
Vasoconstriction, proliferation, and inflammation drive pulmonary hypertension, requiring research into improved treatments.
Why the study?
Despite progress in understanding molecular mechanisms of pulmonary hypertension, further research is needed to integrate these changes into better pathophysiological understanding and treatments, especially for non-PAH subtypes.
Provides a comprehensive overview of the shared and distinct pathophysiological mechanisms, including endothelial dysfunction, inflammation, and right ventricular changes, across the spectrum of pulmonary hypertension.
Current mechanistic understanding of pulmonary hypertension warrants no practice change; leaves open targeted therapy translation.
No takes yet. Share an insight, caveat, or question.
Martin R. Wilkins (2012) conducted a review in Pulmonary hypertension. Pulmonary hypertension is a complex disorder driven by vasoconstriction, cellular proliferation, and inflammation, with further research needed to translate molecular insights into improved treatments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: